Head and Neck

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(ALX) ASPEN-03 / AT148003A PHASE 2 STUDY OF ALX148 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMADr Brandon MeyersOpen to recruitmentNCT04675294
(JCC) SHINE / HNSBRTA Phase 2 Study of SBRT for Squamous Cell Carcinoma of the Head and NeckDr Justin LeeOpen to recruitmentNCT04435938
(Merck) MK-7902-009A Phase 2, randomized, open-label three-arm clinical study to evaluate the safety and efficacy of lenvatinib (E7080/MK-7902) in combination with pembrolizumab (MK-3475) versus standard of care chemotherapy and lenvatinib monotherapy in participants with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) that have progressed after platinum therapy and immunotherapy (PD-1/PD-L1 inhibitors) (LEAP-009)Dr Baskoro (Adi) KartoloSuspended/On holdNCT04428151
Download PDF